breaking bad news and motivational interviewing Flashcards
setting up the interview
privacy, involve significant others
sit down, allow the patient to dress before giving results
manage time constraints
perceptions
use open ended questions to get an idea of how the patient percieves the medical situation
invitation
‘how would you like me to give you the test results’
knowledge
give information in small chunks and check periodically as to the patients understanding
emotions
observe emotions, acknowldge them, identify the reasonn for them, ask the patient how thy are feeling
strategy and summary
give the patient a clear plan
discuss prognosis
smokers who are ready to quit should be assisted by
agreeing on a quit date
identifying smoking triggers and discussing quit strategies
providing self-help materials
prescribing pharmacotherapy based on clinical suitability and patient preference
arranging follow-up visits every 1-2 weeks to prevent relapse
considering referral to a quit program
varenicline
the most effective monotherapy
nausea occurs in some people but this can be minimised by taking the tablet with food
options for oral NRT
varenicline
bupropion
things you can arrange for smokers
refer to quit program eg. quitline who may send patients a quitbook
when to consider inpatient or residental assisted withdrawal of alcohol
- drinks >30 units per day
- score of >30 on SADQ
- Hx of epilepsy or withdrawal related seizures or delirium tremens during previous withdrawals
- needs concurrent withdrawal from alcohol and benzodiazepines
- psychiatric or physical comorbidity
methods of promoting alcohol abstinence
consider acamprosate or oral naltrexone in combination with individual psychological therapy eg. CBT, behavioural therapies or social network and environment-based therapies that focusses specifically on alcohol misuse
SADQ
severity of alcohol dependance questionnire
self administered 20 item questionaire designed by WHO to measure seveerity of dependance on alcohol
oral drug options for promoting alcohol abstinence
naltrexone or acamprosate